ABOUT THIS PODCAST
Despite the passage of the Inflation Reduction Act, drug prices continue to rise. How are manufacturers using the patent, drug approval process, and courts to keep drug prices high, and what are the legislative solutions to these practices?
SHOW NOTES
- The Campaign for Sustainable Rx Pricing
- ASHP Podcast: Doses and Dollars: The Latest on New Drug Pricing Models
SPEAKERS
- Lauren Aronson, BA
Partner, Mehlman Consulting - Tom Kraus, BS, MHS, JD
Chief Advocacy Officer and VP of Government Relations
ASHP





